Emergency Surgery in a Critically Ill Patient with Major Drug-Induced Bleeding and Severe Ischaemic Heart Failure

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245.Search in Google Scholar

2. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15:486-93.10.1093/europace/eus33323220354Search in Google Scholar

3. Liew A, Eikelboom JW, O’Donnell M, Hart RG. Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants. Can J Cardiol. 2013;29:S34-44.10.1016/j.cjca.2013.04.01323790596Search in Google Scholar

4. Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, et al. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP). Arch Cardiovasc Dis. 2013;106:382-93.10.1016/j.acvd.2013.04.00923810130Search in Google Scholar

5. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.10.1097/EJA.0b013e32835f4d5b23656742Search in Google Scholar

6. Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology. 2011;43:682-92.10.1097/PAT.0b013e32834bf5f422081129Search in Google Scholar

7. Blasi A, Muñoz G, de Soto I, Mellado R, Taura P, Rios J, et al. Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement. Thromb Res. 2015;136:669-72.10.1016/j.thromres.2015.07.00326232350Search in Google Scholar

8. Yao Y, Zhang JH, Tang XF, He C, Ma YL, Xu JJ, et al. Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention. Chin Med J 2016;129:2269-74.10.4103/0366-6999.190664504001027647183Search in Google Scholar

9. Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234-43.10.1161/CIRCULATIONAHA.113.002283670118123935011Search in Google Scholar

10. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609-1678.10.1093/europace/euw29527567465Search in Google Scholar

11. Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310:1462-72.10.1001/jama.2013.27878724101118Search in Google Scholar